SeaStar Medical Holding (ICU) Change in Accured Expenses (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Change in Accured Expenses came in at $629000.0 in Q1 2026, up 838.81% YoY from $67000.0 in Q1 2025, and down 44.87% on a QoQ basis from $1.1 million in Q4 2025.
SeaStar Medical Holding (ICU) Change in Accured Expenses (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Change in Accured Expenses data on file, last reported at $629000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 838.81% year-over-year to $629000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $562000.0 (down 70.74% YoY) and the FY2024 annual result came in at $1.9 million, changed N/A from the prior year.
- Change in Accured Expenses fell to $629000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q4 2022 to a low of -$1.4 million in Q2 2025.
- A 5-year average of $305133.3 and a median of $195000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2025 — Change in Accured Expenses sank 305.39% — and 2026, when it soared 838.81%.
- Tracing ICU's Change in Accured Expenses over 5 years: stood at $1.6 million in 2022, then plunged by 144.29% to -$698000.0 in 2023, then surged by 297.71% to $1.4 million in 2024, then retreated by 17.32% to $1.1 million in 2025, then slumped by 44.87% to $629000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $629000.0 (Q1 2026), $1.1 million (Q4 2025), and $164000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 571,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 571,000.00 |
| Jun 30, 2026 | 571,000.00 |
| Mar 31, 2026 | 629,000.00 |
| Mar 31, 2026 | 629,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 164,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Jun 30, 2025 | -1.37 Mn |
| Jun 30, 2025 | -1.37 Mn |
| Mar 31, 2025 | 67,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | -194,000.00 |
| Sep 30, 2024 | -194,000.00 |
| Jun 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 668,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |